A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.

Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Following these changes, the company has also seen the addition of four new directors * Robert Alan Beardsley, Joseph Bishop, ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...